FRM
CHE icon

Fox Run Management’s Chemed CHE Stock Holding History

Fox Run Management’s Portfolio CHE Stock Details CHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-793
Closed -$488K – 909
2025
Q1 		$488K Buy
793
+391
+97% +$222K 0.08% 507
2024
Q4 		$213K Sell
402
-271
-40% -$153K 0.04% 740
2024
Q3 		$404K Buy
673
+126
+23% +$71.4K 0.09% 434
2024
Q2 		$297K Buy
+547
New +$313K 0.06% 557
2024
Q1 		– Sell
-671
Closed -$392K – 789
2023
Q4 		$392K Buy
+671
New +$375K 0.1% 389

Other funds holding CHE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Fox Run Management's CHE Position: Q2 2025 in Review

Fox Run Management sold out of Chemed (CHE) in Q2 2025, closing a stake of 793 shares — an estimated $488K sold.

Fox Run Management first reported a position in CHE in Q4 2023 and held it in 5 quarters. The position peaked at $488K in Q1 2025. 538 funds tracked by Wall St. Rank hold CHE as of Q2 2025.

  • Fox Run Management reported no remaining Chemed position as of Q2 2025 after selling out during the quarter.
  • Fox Run Management sold 793 Chemed shares in Q2 2025, an estimated $488K.
  • Fox Run Management first reported a position in Chemed in Q4 2023 and held it in 5 quarters.
  • Fox Run Management's Chemed position peaked at $488K in Q1 2025.
  • 538 funds tracked by Wall St. Rank held Chemed as of Q2 2025.

Based on Fox Run Management's 13F filing for Q2 2025, filed 6 Aug 2025.